• 1
    Cripe LD. Adult acute leukemia. Curr Probl Cancer 1997; 21: 164.
  • 2
    Leukemia Classifications [Online]. 2010 [cited 2010 May 13]; Available at URL:
  • 3
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun MJ. Cancer statistics. CA Cancer J Clin 2007; 57: 4366.
  • 4
    Ries LAG,Smith MA,Gurney JG,Linet M,Tamra T,Young JL,Bunin GR. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1999. Pub. no. 99–4646. Bethesda, MD: National Cancer Institute 1999; p 189.
  • 5
    Porcu P,Farag S,Marcucci G,Cataland SR,Kennedy MS,Bissell M. Leukocytoreduction for acute leukemia. Ther Apher 2002; 6: 1523.
  • 6
    Gajjar A,Ribeiro R,Hancock ML,Rivera GK,Mahmoud H,Sandlund JT,Crist WM,Pui CH. Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood 1995; 86: 12921295.
  • 7
    Hoelzer D,Thiel E,Loffler H,Buchner T,Ganser A,Heil G,Koch P,Freund M,Diedrich H,Ruhl H. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123131.
  • 8
    Henze G,Fengler R,Hartmann R,Kornhuber B,Janka-Schaub G,Niethammer D,Riehm H. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 1991; 78: 11661172.
  • 9
    Campana D,Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry 1999; 38: 139152.
  • 10
    Campana D. Status of minimal residual disease testing in childhood haematological malignancies. Br J Haematol 2008; 143: 481489.
  • 11
    Shook D,Coustan-Smith E,Ribeiro RC,Rubnitz JE,Campana D. Minimal residual disease quantitation in acute myeloid leukemia. Clin Lymphoma Myeloma 2009; 9 Suppl 3: S281285.
  • 12
    Cave H,van der Werff ten Bosch J,Suciu S,Guidal C,Waterkeyn C,Otten J,Bakkus M,Thielemans K,Grandchamp B,Vilmer E. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European organization for research and treatment of cancer–childhood leukemia cooperative group. N Engl J Med 1998; 339: 591598.
  • 13
    Szczepanski T. Why and how to quantify minimal residual disease in acute lymphoblastic leukemia? Leukemia 2007; 21: 622626.
  • 14
    van der Velden VH,Hochhaus A,Cazzaniga G,Szczepanski T,Gabert J,van Dongen JJ. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: Principles, approaches, and laboratory aspects. Leukemia 2003; 17: 10131034.
  • 15
    Coustan-Smith E,Sancho J,Behm FG,Hancock ML,Razzouk BI,Ribeiro RC,Rivera GK,Rubnitz JE,Sandlund JT,Pui CH, et al. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood 2002; 100: 5258.
  • 16
    Flohr T,Schrauder A,Cazzaniga G,Panzer-Grumayer R,van der Velden V,Fischer S,Stanulla M,Basso G,Niggli FK,Schafer BW, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 771782.
  • 17
    Ring AE,Zabaglo L,Ormerod MG,Smith IE,Dowsett M. Detection of circulating epithelial cells in the blood of patients with breast cancer: Comparison of three techniques. Br J Cancer 2005; 92: 906912.
  • 18
    Novak J,Georgakoudi I,Wei X,Prossin A,Lin CP. In vivo flow cytometer for real-time detection and quantification of circulating cells. Opt Lett 2004; 29: 7779.
  • 19
    Lee H,Alt C,Pitsillides CM,Puoris'haag M,Lin CP. In vivo imaging flow cytometer. Opt Express 2006; 14: 77897800.
  • 20
    Boutrus S,Greiner C,Hwu D,Chan M,Kuperwasser C,Lin CP,Georgakoudi I. Portable two-color in vivo flow cytometer for real-time detection of fluorescently-labeled circulating cells. J Biomed Opt 12: 020507, 2007.
  • 21
    Wei X,Sipkins DA,Pitsillides CM,Novak J,Georgakoudi I,Lin CP. Real-time detection of circulating apoptotic cells by in vivo flow cytometry. Mol Imaging 2005; 4: 415416.
  • 22
    Sipkins DA,Wei X,Wu JW,Runnels JM,Cote D,Means TK,Luster AD,Scadden DT,Lin CP. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005; 435: 969973.
  • 23
    He W,Wang H,Hartmann LC,Cheng JX,Low PS. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci U SA 2007; 104: 1176011765.
  • 24
    Tkaczyk ER,Zhong CF,Ye JY,Myc A,Thomas T,Cao Z,Duran-Struuck R,Luker KE,Luker GD,Norris TB, et al. In vivo monitoring of multiple circulating cell populations using two-photon flow cytometry. Opt Commun 2008; 281: 888894.
  • 25
    Georgakoudi I,Solban N,Novak J,Rice WL,Wei X,Hasan T,Lin CP. In vivo flow cytometry: A new method for enumerating circulating cancer cells. Cancer Res 2004; 64: 50445047.
  • 26
    Mullaney PF,Van Dilla MA,Coulter JR,Dean PN. Cell sizing: A light scattering photometer for rapid volume determination. Rev Sci Instrum 1969; 40: 10291032.
  • 27
    Salzman GC,Crowell JM,Martin JC,Trujillo TT,Romero A,Mullaney PF,LaBauve PM. Cell classification by laser light scattering: Identification and separation of unstained leukocytes. Acta Cytol 1975; 19: 374377.
  • 28
    Steen HB. Simultaneous separate detection of low angle and large angle light scattering in an arc lamp-based flow cytometer. Cytometry 1986; 7: 445449.
  • 29
    Ost V,Neukammer J,Rinneberg H. Flow cytometric differentiation of erythrocytes and leukocytes in dilute whole blood by light scattering. Cytometry 1998; 32: 191197.
  • 30
    Backman V,Gopal V,Kalashnikov M,Badizadegan K,Gurjar R,Wax A,Georgakoudi I,Mueller M,Boone CW,Dasari RR, et al. Measuring cellular structure at submicrometer scale with light scattering spectroscopy. IEEE J Sel Top Quantum Electron 2001; 7: 887893.
  • 31
    Wax A,Yang C,Backman V,Badizadegan K,Boone CW,Dasari RR,Feld MS. Cellular organization and substructure measured using angle-resolved low-coherence interferometry. Biophys J 2002; 82: 22562264.
  • 32
    Hunter M,Backman V,Popescu G,Kalashnikov M,Boone CW,Wax A,Gopal V,Badizadegan K,Stoner GD,Feld MS. Tissue self-affinity and polarized light scattering in the born approximation: A new model for precancer detection. Phys Rev Lett 97: 138102, 2006.
  • 33
    Mujat C,Greiner C,Baldwin A,Levitt JM,Tian F,Stucenski LA,Hunter M,Kim YL,Backman V,Feld M, et al. Endogenous optical biomarkers of normal and human papillomavirus immortalized epithelial cells. Int J Cancer 2008; 122: 363371.
  • 34
    Mourant JR,Bigio IJ,Boyer JD,Johnson TM,Lacey J,Bohorfush AG,Mellow AH. Evidence of intrinsic differences in the light scattering properties of tumorigenic and nontumorigenic cells. Cancer 1998; 84: 366374.
  • 35
    Bigio IJ,Brown SG,Briggs G,Kelley C,Lakhani S,Pickard D,Ripley P,Rose IG. Saunder. Diagnosis of breast cancer using elastic-scattering spectroscopy: Preliminary clinical results. J Biomed Opt 2000; 5: 221228.
  • 36
    Mirabal YN,Chang SK,Atinson EN,Malpica A,Follen M,Richards-Kortum R. Reflectance spectroscop for in vivo detection of cervical cancer. J Biomed Opt 2002; 7: 587594.
  • 37
    Huang P,Hunter M,Georgakoudi I. Confocal light scattering spectroscopic imaging system for in situ tissue characterization. Appl Opt 2009; 48: 25952599.
  • 38
    Hurwitz R,Hozier J,LeBien T,Minowada J,Gajl-Peczalska K,Kubonishi I,Kersey J. Characterization of a leukemic cell line of the pre-B phenotype. Int J Cancer 1979; 23: 174180.
  • 39
    Gélébart B,Tinet E,Tualle JM,Avrillier S. Phase function simulation in tissue phantoms: A fractal approach. J Pure Appl Opt 1996; 5: 377388.
  • 40
    Schmitt JM,Kumar G. Optical scattering properties of soft tissue: A discrete particle model. Appl Opt 1998; 37: 27882797.
  • 41
    Xu M,Alfano RR. Fractal mechanisms of light scattering in biological tissue and cells. Opt Lett 2005; 30: 30513053.
  • 42
    Hsaio A,Hunter M,Greiner C,Gupta S,Georgakoudi I. Non-invasive identification of subcellular organization and nuclear morphology features associated with leukemic cells using light scattering spectroscopy. J Biomed Opt 2011; 16: 037007.
  • 43
    Young B,Heath JW. Wheater's functional histology: A text and colour atlas. London: Elsevier Science Limited; 2000.
  • 44
    Ruban GI,Kosmacheva SM,Goncharova NV,Van Bockstaele D,Loiko VA. Investigation of morphometric parameters for granulocytes and lymphocytes as applied to a solution of direct and inverse light-scattering problems. J Biomed Opt 2007; 12: 044017.
  • 45
    Scott Brock R,Hu X,Weidner DA,Mourant JR,Lu JQ. Effect of detailed cell structure on light scattering distribution: FDTD study of a B-cell with 3D structure constructed from confocal images. J Quant Spectrosc Radiat Transf 2006; 102: 2536.